2013a;36:294551
The ELISA has a reported 88% cross-reactivity with the GLP-1 (136) amide, 93% cross-reactivity with the GLP-1 (736) amide, and non-detectable cross reactivity with the glycine-extended GLP-1 (137) amide, the GLP-1 (737) amide, and exenatide
Key Takeaways GLP-1 medications are not fertility treatments, but the weight loss and metabolic improvements they cause can restart ovulation in women who had stopped cycling regularly
Compounded Medication Additional Considerations According to company disclaimer: "We encourage all prospective users of compounded medications to speak with their provider about the specific risks and benefits that may come with the use of compounded medication." Potential variables between compounded formulations include bioavailability differences, compounding methodology variations, storage and handling affecting potency, and batch-to-batch concentration variations
Please note that some clients may experience slight swelling or redness after treatment
Mix into protein shakes , yogurt, or water